CLINICAL_TRIALS
trial_result
· 2014-05-22
Clinical Trial Update: Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old [Phase 3]
Summary
Open-label safety study of Xerese Cream for recurrent herpes labialis in children aged 6-11 was completed and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Meda Pharmaceuticals | Conditions: Herpes Labialis | Phase 3 | Status: COMPLETED | Results posted: 2014-05-22